A novel mouse model for checkpoint inhibitor-induced adverse events

Immune checkpoint inhibitors have demonstrated significant efficacy in the treatment of a variety of cancers, however their therapeutic potential is limited by abstruse immune related adverse events. Currently, no robust animal model exists of checkpoint inhibitor-induced adverse events. Establishin...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Kieran, Iuga, Alina, Tocheva, Anna S., Mor, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877613/
https://www.ncbi.nlm.nih.gov/pubmed/33571254
http://dx.doi.org/10.1371/journal.pone.0246168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877613/
https://www.ncbi.nlm.nih.gov/pubmed/33571254
http://dx.doi.org/10.1371/journal.pone.0246168

Ejemplares similares